Skip to content

Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management

Real-world Incremental Costs of Opportunistic Upper Gastrointestinal Endoscopy Added to Colorectal Cancer Screening and the Economic Burden of Gastric Cancer Management: a Retrospective Cohort Study - Study Protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07522320
Acronym
EconROGCAS
Enrollment
250
Registered
2026-04-13
Start date
2026-01-02
Completion date
2026-07-21
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Adenocarcinoma, Gastric Cancer (GC)

Keywords

Screening, Gastric Cancer, economic

Brief summary

Data will be extracted from routinely collected hospital databases.

Detailed description

Electronic medical records; Endoscopy and pathology databases; Surgical and hospitalization records; Oncology treatment databases; Imaging and diagnostic services; Institutional mortality records.

Interventions

None listed

Sponsors

Unidade Local De Saúde Do Norte Alentejano
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Cohort A: * Eligible participants were adults aged 50 to 75 years or older who had been referred for colonoscopy as part of the national colorectal cancer screening programme, following a positive FIT. To be included, individuals also needed to provide informed consent and agree to undergo an EGD endoscopy for the screening of potential upper gastrointestinal precancerous conditions or lesions. Cohort B: * Patients with gastric adenocarcinoma, diagnosed and treated at Unidade Local de Saúde do Alto Alentejo between 2015 and 2025.

Exclusion criteria

Cohort A: *

Design outcomes

Primary

MeasureTime frameDescription
Stage distribution at diagnosisAt diagnosis (2015-2020)Distribution of gastric cancer stages at diagnosis (Stage I-IV) according to TNM classification (expressed as percentage of patients per stage).
Treatment patternsDuring initial treatment period (2015-2020)Types of treatment received by patients with gastric cancer, including surgery, chemotherapy, radiotherapy, and palliative care
Overall survivalFrom diagnosis up to last follow-up (2015-2020)Overall survival of patients diagnosed with gastric cancer (measured in months).

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026